Conduit Pharmaceuticals (NASDAQ: CDT) is owned by 3.05% institutional shareholders, 67.10% Conduit Pharmaceuticals insiders, and 29.85% retail investors. Andrew Regan is the largest individual Conduit Pharmaceuticals shareholder, owning 45.77M shares representing 47.68% of the company. Andrew Regan's Conduit Pharmaceuticals shares are currently valued at $4.53M.
If you're new to stock investing, here's how to buy Conduit Pharmaceuticals stock.